FDA Inspection 1280796 - North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding - September 05, 2025
FDA Inspection 1280796 for North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding on September 05, 2025. Classification: Voluntary Action Indicated (VAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1280796 for North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding on September 05, 2025. Classification: Voluntary Action Indicated (VAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
September 5, 2025
Product Type
Drugs
ID: 19a558d4-571f-445d-b4b1-c31f73fd6956
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox